Evidence map›Paper›PMID 34199077›Full record

ReviewViruses2021

From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.

John F Atkins, Kate M O'Connor, Pramod R Bhatt, Gary Loughran

Abstract readReview
In one paragraph

Review in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John F AtkinsSchools of Biochemistry and Microbiology, University College Cork, T12 XF62 Cork, Ireland.
Kate M O'ConnorSchools of Biochemistry and Microbiology, University College Cork, T12 XF62 Cork, Ireland.ORCID 0000-0002-4862-4918
Pramod R BhattSchools of Biochemistry and Microbiology, University College Cork, T12 XF62 Cork, Ireland.ORCID 0000-0003-1451-9105
Gary LoughranSchools of Biochemistry and Microbiology, University College Cork, T12 XF62 Cork, Ireland.ORCID 0000-0002-2683-5597

Funding

Irish Research Council IRCLA/2019/74
6 · The paper itself

Abstract

Many viruses, especially RNA viruses, utilize programmed ribosomal frameshifting and/or stop codon readthrough in their expression, and in the decoding of a few a UGA is dynamically redefined to specify selenocysteine. This recoding can effectively increase viral coding capacity and generate a set ratio of products with the same N-terminal domain(s) but different C-terminal domains. Recoding can also be regulatory or generate a product with the non-universal 21st directly encoded amino acid. Selection for translation speed in the expression of many viruses at the expense of fidelity creates host immune defensive opportunities. In contrast to host opportunism, certain viruses, including some persistent viruses, utilize recoding or adventitious frameshifting as part of their strategy to evade an immune response or specific drugs. Several instances of recoding in small intensively studied viruses escaped detection for many years and their identification resolved dilemmas. The fundamental importance of ribosome ratcheting is consistent with the initial strong view of invariant triplet decoding which however did not foresee the possibility of transitory anticodon:codon dissociation. Deep level dynamics and structural understanding of recoding is underway, and a high level structure relevant to the frameshifting required for expression of the SARS CoV-2 genome has just been determined.

Indexed as

Immune EvasionAntiviral AgentsCodon, TerminatorDNA VirusesFrameshifting, RibosomalHistocompatibility Antigens Class INucleic Acid ConformationPeptidesProtein BiosynthesisRNA VirusesAntiviral AgentsCodon, TerminatorHistocompatibility Antigens Class IPeptidesbet hedgingcancercodon redefinitionDRiPsribosomal frameshiftingribosome structureselenocysteinestop codon readthroughStopGo

Identifiers

PMID34199077
PMCPMC8310308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.